Tuberous Sclerosis treatment

Details for Australian Patent Application No. 2007211613 (hide)

Owner Novartis AG

Inventors Stumm, Michael; Lane, Heidi; Elmroth, Ingrid; Benedetto, John; Sellers, William; Lebwohl, David; Berg, William

Agent Davies Collison Cave

Pub. Number AU-B-2007211613

PCT Pub. Number WO2007/088034

Priority 0603568.7 22.02.06 GB; 0604593.4 07.03.06 GB; 0609698.6 16.05.06 GB; 0605760.8 22.03.06 GB; 0602123.2 02.02.06 GB

Filing date 31 January 2007

Wipo publication date 9 August 2007

Acceptance publication date 28 April 2011

International Classifications

A61K 31/436 (2006.01)

A61K 31/351 (2006.01) - not condensed with another ring

A61K 31/365 (2006.01) - Lactones

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

14 August 2008 PCT application entered the National Phase

  PCT publication WO2007/088034 Priority application(s): WO2007/088034

28 April 2011 Application Accepted

  Published as AU-B-2007211613

25 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007211617-Hydrogel

2007211610-Thin wall header with a variable crosssection for solar absorption panels